For SCLC, we discovered CEA-P as a new IHC marker with a diagnostic sensitivity and specificity comparable to TTF-1 and that the combined use of both markers significantly increases the sensitivity for SCLC. The gene discussed is CEACAM5; the disease is small cell lung carcinoma.